Finance

Lists
Why is SBS up 3,01%?
Dive Deeper
SBS:FRA
Stratec SE
22,25 €
+3,01%
(+0,65) 1D
12-окт., 08:02:10 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for SBS...
Open
22,25 €
High
22,25 €
Low
22,25 €
Mkt. cap
279,63 млн
Avg. vol.
51,00
Volume
0,00
Dividend
2,70%
Quarterly dividend
0,15 €
Ex-dividend date
2026-ж., 24-июн.
52-wk high
30,05 €
52-wk low
16,38 €
EPS
-0,03 €
Shares outstanding
11,96 млн
No. of employees
1 миң
Open
22,25 €
High
22,25 €
Low
22,25 €
Mkt. cap
279,63 млн
Avg. vol.
51,00
Volume
0,00
Dividend
2,70%
Quarterly dividend
0,15 €
Ex-dividend date
2026-ж., 24-июн.
52-wk high
30,05 €
52-wk low
16,38 €
EPS
-0,03 €
Shares outstanding
11,96 млн
No. of employees
1 миң
News stories
From web sources and news partners
Profile
STRATEC SE is a company with worldwide operations that designs and manufactures fully automated analyzer systems for partners in clinical diagnostics and biotechnology - particularly in the field of in-vitro-diagnostics. As a classic original equipment manufacturer supplier, STRATEC produces its systems almost exclusively on behalf of its customers. Alongside the systems themselves, the company also provides sample preparation solutions, system software and integrated laboratory software. STRATEC is also responsible for development documentation, testing, delivery of systems, and the supply of spare parts and complex consumables for diagnostic and medical applications. STRATEC's customers are well known diagnostic companies like DiaSorin, Abbott, SIEMENS, Bio-Rad or Hologic. Wikipedia
About Stratec SE
CEO-
Employees1,38 миң
Founded1979
Headquarters-
SectorMedical device
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
57,00 млн
75,28 млн
53,43 млн
59,11 млн
Cost of goods sold
43,70 млн
56,31 млн
43,22 млн
43,87 млн
Cost of revenue
43,70 млн
56,31 млн
43,22 млн
43,87 млн
Research and development expenses
1,59 млн
2,78 млн
1,72 млн
1,49 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8,47 млн
10,82 млн
8,82 млн
9,64 млн
Operating expense
9,78 млн
11,19 млн
10,30 млн
9,66 млн
Total operating expenses
53,48 млн
67,50 млн
53,53 млн
53,54 млн
Operating income
3,52 млн
7,78 млн
-104,00 миң
5,57 млн
Other non operating income
-117,00 миң
219,00 миң
-65,00 миң
61,00 миң
EBT including unusual items
2,38 млн
-826,00 миң
-1,16 млн
5,43 млн
EBT excluding unusual items
2,38 млн
5,55 млн
-1,16 млн
5,43 млн
Income tax expense
878,00 миң
3,52 млн
557,00 миң
1,27 млн
Effective tax rate
36,91%
-426,03%
-48,18%
23,35%
Other operating expenses
-274,00 миң
-2,41 млн
-235,00 миң
-1,46 млн
Net income
1,50 млн
-4,34 млн
-1,71 млн
4,16 млн
Net profit margin
2,63%
-5,77%
-3,21%
7,04%
Earnings per share
-
-
-
-
Interest and investment income
33,00 миң
8,00 миң
34,00 миң
55,00 миң
Interest expense
-1,06 млн
-955,00 миң
-1,02 млн
-260,00 миң
Net interest expenses
-1,02 млн
-947,00 миң
-987,00 миң
-205,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
8,04 млн
10,71 млн
4,45 млн
10,03 млн
Gain or loss from assets sale
13,00 миң
3,00 миң
-94,00 миң
-9,00 миң
AI content may include mistakes. Learn more
Google колдонмолору